The global demand for Exosomes Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020 - 2026.
Exosomes refer to an extracellular vesicle that contains protein, RNA, and DNA of the cells that produce them. Exosome therapy is the new treatment used in the early stage of cancer detection. Exosomes extracted from cow milk are majorly used to deliver therapeutic molecules against breast and lung cancers. Exosomes have huge potential to act like vehicles for drug delivery because they have natural material transportation properties such as high biocompatibility and intrinsic long-term circulation. Intercellular communication through exosomes supposed to be involved in the pathogenesis of a variety of disorders such as cancer, inflammatory and neurodegeneration diseases.
The rising prevalence of cancer cases across the globe, along with technological advancements in exosomes isolation and analytical procedures, are the major factors driving the exosomes market over the forecast period. Moreover, increasing advanced applications of exosomes in therapeutic and the rising emphasis on early diagnosis of cancer are highly contributing to the growth of the global exosomes market. The rising healthcare expenditure and growing awareness related to healthcare creates a positive impact on the growth of the exosomes market globally. Furthermore, increasing research and development in oncology by private and public institutions, coupled with strong pipeline products of key players, are expected to create a lucrative opportunity for the market in the coming years.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of exosomes.
The entire exosomes market has been sub-categorized into workflow, biomolecule type and application. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By Biomolecule Type
- Isolation Methods
- Immunocapture on beads
- Downstream Analysis
- Cell Surface Marker Analysis using Flow Cytometry
- Protein analysis using Blotting & ELISA
- RNA analysis with NGS & PCR
- Proteomic analysis using Mass Spectrometry
- Non-Coding RNAs
- Proteins /Peptides
- DNA Fragments
- Neurodegenerative Diseases
- Cardiovascular Diseases
- Infectious Diseases
This section covers regional segmentation which accentuates on current and future demand for exosomes market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Europe Exosomes Market By Revenue (USD MN)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the exosomes market include Danaher (Beckman Coulter Inc.), Diagenode Inc., Fujifilm Holdings Corporation, Hitachi Chemical Diagnostics Inc., Lonza, MBL International, Miltenyi Biotec, Novus Biologicals, Qiagen, Thermo Fisher Scientific Inc. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.